Insilico Medicine Secures $110 Million Series E Financing to Advance AI-Driven Drug Discovery Innovation (IMAGE)
Caption
The funds raised in this round will be directed to advance Insilico's innovative drug pipeline and AI platform developments.
Credit
Insilico Medicine
Usage Restrictions
None
License
Original content